Navigation Links
Antiviral therapy during compensated cirrhosis most cost-effective approach
Date:5/27/2010

Researchers at the UCLA Medical Center found that antiviral therapy during compensated cirrhosis, when compared with all other strategies, is the most cost-effective approach to treating patients with advanced liver disease due to hepatitis C (HCV) infection. Full details appear in the June issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).

HCV is generally treated once significant scarring has occurred but before patients develop advanced scarring, i.e. cirrhosis. The standard antiviral regimen used to treat HCVpegylated interferon and ribavirin (PEG/RBV)can cause harsh side effects and is considered by some medical professionals to be of uncertain benefit in patients with advanced liver disease.

Furthermore, HCV genotype 1, the type that afflicts most HCV patients, is least responsive to antiviral treatment. According to the HCV Advocate, genotype is the most important predictor of successful treatment response and also dictates the dose of ribavirin and length of therapy. People with genotype 1 have about a 50% chance of successful treatment and people with genotypes 2 or 3 have about a 70-90% chance of a successful treatment response. In addition, people with genotypes 2 or 3 are prescribed a lower dose of ribavirin than people with genotype 1.

Using a Markov model, the UCLA team set out to determine the most cost-effective timing for PEG/RBV therapy in patients with advanced liver disease infected with genotype 1 HCV by comparing treatment at different stages of advanced HCV disease over a 17-year period.

The study population of 4,000 patients was evenly divided into 4 different treatment strategies. The control group did not receive antiviral treatment. In the first treatment strategy, antiviral treatment was initiated in patients with compensated HCV cirrhosis. In the second treatment strategy, patients were t
'/>"/>

Contact: Dawn Peters
medicalnews@wiley.com
781-388-8408
Wiley-Blackwell
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Researchers find broad spectrum antiviral that fights multitude of viruses
2. Vaccination, antivirals and social distancing may blunt impact of H1N1 influenza
3. New Study: Improved Immune System with Gene-Eden, a Natural Antiviral Supplement that Targets Chronic Viruses
4. Targeted therapy prolongs life in patients with HER2-positive breast cancer
5. PharmMD Secures Investments to Fund New Opportunities in Medication Therapy Management
6. More smokers kick the habit with extended nicotine patch therapy, Penn research shows
7. Experts Issue Warning on Prostate Hormone Therapy
8. ASGCT: Gene Therapy Shows Promise for Patients with Pompe Disease
9. AAPM statement on quality radiation therapy
10. Congress Urged to Take Immediate Action to Ensure Frail Patients Continue to Receive Critical Therapy Services
11. Intensive Insulin Therapy Wont Boost Septic Shock Survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... October 31, 2014 Becker's Hospital ... list "100 Hospitals and Health Systems With Great ... list lead the nation in cardiovascular and thoracic ... research, and all have received recognition from reputable ... the fifth time Becker's Hospital Review has compiled ...
(Date:10/31/2014)... (PRWEB) October 31, 2014 TheHardwareCity.com is ... for winter. Many quality electric space heaters are available ... the superior Broan-Nutone Big Heat 1500w portable electric space ... newly available at TheHardwareCity.com, offers an energy efficient way ... cabin. The ceramic heating elements produce 1500 Watts, ensuring ...
(Date:10/31/2014)... PA (PRWEB) October 31, 2014 Fundraising support ... are greater gains than losses. At noon on Monday, November ... Memorial Hospital (SSMH), greater than 20 Susquehanna Health (SH) ... locks to raise awareness and funds for the new Cancer ... shave participants’ heads for this act of love and support ...
(Date:10/31/2014)... division is central to life. The last stage, when ... scientists since the dawn of cell biology in the ... notoriously difficult to study this final step, when the ... , The name given to this process by those ... the sense of a highly active and organized series ...
(Date:10/31/2014)... October 31, 2014 Springboard Biodiesel, ... its small scale BioPro™ biodiesel processors, announced on ... further improve the performance and efficiency of small-scale ... GL95/MC12/BD380 trio will recover more than 99% ... with the glycerin by-product produced while making biodiesel. ...
Breaking Medicine News(10 mins):Health News:Becker's Hospital Review Names 100 Hospitals, Health Systems With Great Heart Programs 2Health News:Becker's Hospital Review Names 100 Hospitals, Health Systems With Great Heart Programs 3Health News:Becker's Hospital Review Names 100 Hospitals, Health Systems With Great Heart Programs 4Health News:Big Heat 1500w Electric Space Heater Now Available at TheHardwareCity.com 2Health News:Susquehanna Health Soldiers + Sailors Memorial Hospital Razing Heads to Fight Cancer 2Health News:Cell division, minus the cells 2Health News:Cell division, minus the cells 3Health News:Springboard Biodiesel Announces Release of New and Unique Methanol Recovery and Glycerin Treatment Equipment 2Health News:Springboard Biodiesel Announces Release of New and Unique Methanol Recovery and Glycerin Treatment Equipment 3
... COLUMBUS, Ohio -- An Ohio State University mathematician and his ... cells and abnormal cells, such as cancer cells, based on ... creating mathematical equations that describe the shape and motion of ... is in its early stages, it represents an entirely new ...
... TUESDAY, Jan. 25 (HealthDay News) -- Elderly patients with ... emergency department often do not comprehend why they are ... or nurses, a new study finds. U.S. researchers ... an emergency department and found that those with cognitive ...
... joined state, community and university partners on Jan. 25 ... health. The grant project will serve more than 1,200 ... cognitive and behavioral development services. Project LAUNCH ... serve children ages birth to 8 years old and ...
... , TUESDAY, Jan. 25 (HealthDay News) -- Epilepsy was the ... Frederic Chopin, according to a new study. Researchers reached ... the musician,s own descriptions of his hallucinations -- including his ... accounts of his life written by pupils and friends such ...
... , TUESDAY, Jan. 25 (HealthDay News) -- Following a series ... Administration is asking an expert panel to vote Tuesday on ... Over the past five years, there have been 68 recalls ... in cardiac arrest in hopes of getting the heart to ...
... ultrasound investigation and a blood test to measure the level ... future heart failure following acute coronary syndromes. This is the ... Sweden. Acute coronary syndromes, such as myocardial infarction and ... medical care and death in Sweden for both women and ...
Cached Medicine News:Health News:Researchers use cell 'profiling' to detect abnormalities -- including cancer 2Health News:Researchers use cell 'profiling' to detect abnormalities -- including cancer 3Health News:Elderly With Dementia, Delirium Confused by ER Visits: Study 2Health News:Federal grant helps LAUNCH improvements in children's health 2Health News:FDA Looking for Tougher Standards for External Defibrillators 2Health News:Ultrasound and a blood test can increase survival after myocardial infarction 2
(Date:10/31/2014)... 2014 Imago BioSciences, Inc., a biotech ... million Series A financing led by Clarus Ventures ... team of accomplished investment and operating professionals dedicated ... round include Frazier Healthcare, Amgen Ventures, and Merck ... and Frazier Healthcare will join the company,s board ...
(Date:10/31/2014)... , October 31, 2014 Investor-Edge ... (NASDAQ: NSPH ), Isis Pharmaceuticals Inc. (NASDAQ: ... HALO ), ACADIA Pharmaceuticals Inc. (NASDAQ: ... research on these five companies can be accessed at: ... 2014, the NASDAQ Composite ended at 4,566.14, up 0.37%, ...
(Date:10/31/2014)... 31, 2014  Encision Inc. (OTCQB:ECIA), a medical device ... electrosurgical burns in minimally invasive surgery, today announced financial ... 30, 2014. The Company posted quarterly net ... of $414 thousand, or $(0.04) per share. These results ... net loss of $50 thousand, or $(0.01) per share, ...
Breaking Medicine Technology:Imago BioSciences Announces $26.5 Million Financing Led by Clarus Ventures 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 4Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 5Encision Reports Second Quarter Fiscal Year 2015 Results 2Encision Reports Second Quarter Fiscal Year 2015 Results 3Encision Reports Second Quarter Fiscal Year 2015 Results 4Encision Reports Second Quarter Fiscal Year 2015 Results 5
... for spine tumorsLAS VEGAS, Feb. 22 For orthopaedic researcher ... a personal as well as a professional mission. Her cousin ... remembers the incredible pain her cousin experienced when the cancer ... Keyak and her colleagues at the University of California, ...
... Health Secretary Everette James today ... million will be awarded from Pennsylvania,s share of ... focus on specific research priorities established and reviewed ... chaired by Secretary James. The priorities for 2008-09 ...
Cached Medicine Technology:Breast Cancer Patients May Have a New Treatment Option When Cancer Spreads 2Breast Cancer Patients May Have a New Treatment Option When Cancer Spreads 3Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds 2Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds 3Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds 4
... Aaron manufactures two groups of flexible ... sterile and non-sterile in three different sizes ... flexible shaft portion of the light). These ... additional light is needed., ,The second ...
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include...
... groups of flexible lighting products. The first ... three different sizes 5", 10", and 15" ... the light). These lights are for use ... ,The second group of flexible lights ...
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include...
Medicine Products: